Malaria in Pregnancy Preventive Alternative Drugs(MiPPAD)

In the News

IHI at the first Malaria World Congress in Melbourne

(Melbourne) Ifakara Health Institute (IHI) was represented by three scientists to the inaugural Malaria World Congress in Melbourne, Australia. Research scientists, Dr. Gerry Killeen and Nancy Matowo took to the …

IHI researcher Nancy on Australian radio SBS

(Melbourne) Ifakara Health Institute (IHI) Research Scientist Nancy Matowo recently was invited to a 26-minute radio interview with the SBS, a Swahili Australian radio, to share her research work and …

Recent Projects

Sustainable, Healthy, Learning Cities and Neighbourhoods

The Sustainable, Healthy, Learning Cities and Neighbourhoods is an exciting project in which IHI works with a consortium of partners from Asia and Africa to 1) develop capacity for improved …

Development of a new tool for malaria mosquito surveillance to improve vector control

Malaria transmission is influenced not only by vector abundance, but as well by demographic traits such as vector species and age structure, as these influence the intensity by which the …

Malaria in Pregnancy Preventive Alternative Drugs

IPTp with SP, in a context of ITNs use, has been already proved to be cost-effective in preventing both clinical malaria in pregnant women and neonatal mortality (Sicuri et al. Unpublished). Mefloquine has the potential to be more efficacious than SP but it is also more expensive and has some tolerability and potentially compliance issues. For this reason, an economic evaluation of IPTp-MQ compared to IPTp-SP is needed.

Furthermore, little is known about the economics of malaria prevention during pregnancy in HIV infected women. To our knowledge, the only economic evaluation that considered HIV status as a factor affecting the effectiveness of IPTp was Wolfe et al (Wolfe et al. 2001). MiPPAD trials offer the opportunity to undertake a cost-effectiveness analysis based on efficacy and effectiveness of preventive interventions addressed to HIV infected and HIV non-infected pregnant women in comparison to SP. More evidence is needed about the economic burden of malaria in pregnancy in Tanzania in order to understand which actual savings, from the societal prospective, can be generated by the prevention of malaria cases through a more efficacious intervention.

Lead Scientists:

Abdulnoor Mulokozi


No items found


European and Developing Countries Trial Partnership

Projects Location

© Ifakara Health Institute (IHI), 2016